Stock listing
NASDAQ:HSTO Histogen Inc Stock
Follow Histogen Inc into a list and get an email when it puts out news.
Delisted NASDAQ:HSTO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:HSTO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Histogen Inc on 6ix
- Decks
- 8 decks · latest Dec 29, 2020
Where Histogen Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HSTO · This page · Delisted | NASDAQ | United States | USD |
| OTC:HSTOQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (December 2020) | IPO roadshow | 22 slides | Dec 29, 2020 |
| Investor Presentation (August 2020) | Investor deck | 23 slides | Aug 7, 2020 |
| 2020 BIO Digital International Conference | Conference | 19 slides | Jun 5, 2020 |
| Conatus Pharmaceuticals — Merger or Acquisition (January 2020) | Merger or acquisition | 26 slides | Jan 30, 2020 |
| Conatus Pharmaceuticals — Corporate Update (May 2019) | Corporate update | 27 slides | May 15, 2019 |
| Conatus Pharmaceuticals — Corporate Update (April 2019) | Corporate update | 30 slides | Apr 2, 2019 |
| Conatus Pharmaceuticals — Corporate Update (September 2014) | Corporate update | 28 slides | Sep 2, 2014 |
| Conatus Pharmaceuticals — Piper Jaffray Healthcare Conference 2013 | Conference | 37 slides | Dec 3, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past) | Director · Feb 7, 2014 – Jun 27, 2019 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past) | Director · Jul 24, 2013 – Jun 27, 2019 · Past |
| Shahzad Malik Other companies: Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 17, 2021 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Dec 6, 2018 · Past); Agenus Inc. (Director · Jun 15, 2016 – Jun 15, 2016 · Past); Aravive Inc (Director · Jun 29, 2015 – Sep 12, 2019 · Past) | Director · Jun 23, 2016 – Jun 23, 2016 · Past |
| Richard W Pascoe Other companies: Zevra Therapeutics, Inc. (Chief Executive Officer, Director · Apr 15, 2015 – Mar 9, 2023 · Past); Apricus Biosciences Inc (CEO & Secretary, Director · Mar 18, 2013 – Jan 23, 2019 · Past); Somaxon Pharmaceuticals Inc (President and CEO, Director · Nov 28, 2008 – Dec 31, 2012 · Past) | President, CEO & Director, Director · May 26, 2020 – Mar 30, 2021 · Past |
| Gail K. Naughton Other companies: TherapeuticsMD, Inc. (Board Member · Since at least Mar 20, 2020); Cel-Sci Corporation (Director · Aug 2, 2022 – Aug 8, 2023 · Past) | See Remarks · May 26, 2020 – Jan 13, 2021 · Past |
| William R Larue Other companies: Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Cadence Pharmaceuticals Inc (SVP, CFO, Treas, Asst Sec · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Feb 6, 2017 – Jun 27, 2019 · Past |
| David T Hagerty Other companies: Ardea Biosciences Inc (Senior VP & CMO · Dec 16, 2011 – Jun 19, 2012 · Past) | EVP, Clinical Development · Oct 1, 2014 – Feb 7, 2019 · Past |
| Alfred P Spada | See Remarks · Feb 1, 2023 – Feb 23, 2023 · Past |
| Gary C Burgess | Sr. VP, Clin. Res. & CMO · Jul 24, 2013 – Feb 7, 2014 · Past |
| Joyce Reyes | See Remarks · Jun 1, 2022 – Mar 10, 2023 · Past |
All 15 people
| Person | Seat |
|---|---|
| Marc Olivier Perret | Director · Jul 24, 2013 – Jul 30, 2013 · Past |
| Michelle L Vandertie | Vice President, Finance · Mar 31, 2017 – Aug 1, 2019 · Past |
| Moya Daniels | See Remarks · Oct 16, 2020 – Jan 13, 2021 · Past |
| Rochelle Fuhrmann | Director · Mar 25, 2021 – Jun 20, 2023 · Past |
| Stephen Chang | Director · May 26, 2020 – Oct 7, 2020 · Past |
Log in to ask 6ix AI your own questions about Histogen Inc.